Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the  Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfill our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free more...


Article type

Case Report


Article page

246-249


Authors Details

Bhagwati Prasad Sharma, Shashikant Sharma*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 102

PDF Downloaded: 75


Management of Coats’ disease with RazumabTM (World’s first biosimilar ranibizumab) and laser photocoagulation: A case report


Case Report

Author Details : Bhagwati Prasad Sharma, Shashikant Sharma*

Volume : 7, Issue : 1, Year : 2021

Article Page : 246-249

https://doi.org/10.18231/j.ijceo.2021.050



Suggest article by email


Abstract

We report a case of a 19-year-old Indian male with stage 2 Coats’ disease who was managed with monthly intravitreal biosimilar ranibizumab injections (n=3) along with laser photocoagulation in the right eye. Post-treatment, significant reductions were seen in the exudation, angioma-like lesions, central macular thickness and edema in the retina. At the last follow-up at 9 months after intravitreal biosimilar ranibizumab initiation, distant vision improved from best corrected visual acuity (BCVA) of 5/60 at baseline to 6/18, and near vision from ‘not able to read’ to N/12 in the right eye.

Keywords: Biosimilar, Coats’ disease, Laser photocoagulation, Ranibizumab.


How to cite : Sharma B P , Sharma S , Management of Coats’ disease with RazumabTM (World’s first biosimilar ranibizumab) and laser photocoagulation: A case report. Indian J Clin Exp Ophthalmol 2021;7(1):246-249

Copyright © 2021 by author(s) and Indian J Clin Exp Ophthalmol. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)